Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity (Q44970580)
Jump to navigation
Jump to search
scientific article published in August 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity |
scientific article published in August 2004 |
Statements
1 reference
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity (English)
1 reference
Chaim Yosefy
1 reference
Eliahu Magen
1 reference
Ada Kiselevich
1 reference
Rita Priluk
1 reference
Daniel London
1 reference
Lior Volchek
1 reference
Reuven J Viskoper
1 reference
1 August 2004
1 reference
1 reference
Identifiers
1 reference